Delayed allergic reactions to omalizumab: Are patients reporting all cases?

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 3, 2008, Pages 785-786

  Barry, Peter J ^a   O'Mahony, Ann ^a   Finnegan, Collette ^a   O'Connor, Terence M ^a  

^a MERCY UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; OMALIZUMAB; SALBUTAMOL;

ADULT; ALLERGIC REACTION; ANAMNESIS; ASTHMA; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFECT; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANAPHYLAXIS; ANTI-ASTHMATIC AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; FEMALE; HUMANS; TIME FACTORS;

EID: 40049106628     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.12.1184     Document Type: Letter

References (1)

1. Limb S.L., Starke P.R., Lee C.E., and Chowdhury B.A. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma. J Allergy Clin Immunol 120 (2007) 1378-1381